G1 Therapeutics and Pepper Bio Announce Global (Excluding
G1 Therapeutics and Pepper Bio Announce Global (Excluding Asia-Pac) License Agreement for Lerociclib ...
Source: globenewswire.com
Stay updated with breaking news from Pepper Bio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
G1 Therapeutics and Pepper Bio Announce Global (Excluding Asia-Pac) License Agreement for Lerociclib ...
- Pepper Bio will Gain Exclusive Rights for the Clinical Development, Regulatory Submissions, and Commercialization of Lerociclib in the US, Europe, Japan, and All Other Global Markets Excluding...
Read more from Haje Jan Kamps at TechCrunch
This week, we are taking a closer look at Pepper Bio's seed pitch deck that landed the company $6.5 million.